Stoke Therapeutics (STOK) Treasury Shares (2023 - 2025)

Stoke Therapeutics has reported Treasury Shares for 3 years, with the latest figure at $1.8 million in Q4 2025.

• For the quarter ending Q4 2025, Treasury Shares rose 43.44% year-over-year to $1.8 million; the trailing twelve-month figure through Dec 2025 stood at $1.8 million (up 43.44% YoY), and the FY2025 full-year result was $1.8 million, up 43.44% from the prior year.
• Treasury Shares for Q4 2025 stood at $1.8 million, up from $1.2 million in the prior quarter.
• The five-year high for Treasury Shares was $1.8 million in Q4 2025, with the low at $1.2 million in Q4 2024.
• Average Treasury Shares over 3 years is $1.5 million, with a median of $1.5 million recorded in 2023.
• Year-over-year, Treasury Shares slipped 19.18% in 2024 and jumped 43.44% in 2025.
• Tracing STOK's Treasury Shares over 3 years: stood at $1.5 million in 2023, then declined by 19.18% to $1.2 million in 2024, then jumped by 43.44% to $1.8 million in 2025.
• The last three Treasury Shares figures came in at $1.8 million (Q4 2025), $1.2 million (Q4 2024), and $1.5 million (Q4 2023), per Business Quant data.

Peer Comparison